FN1 and ovarian cancer: Additionally, in ovarian cancer cells, where mutp53 or ENTPD5 depletion did not affect ITGA5 and ITGB1 expression levels (Supplemental Fig. 1), we observed no inhibition of FN binding by mutp53 or ENTPD5 depletion (Supplemental Fig. 3).